By GSK | April 3, 2018

GSK Reaches Agreement with Novartis to Acquire Full Ownership of Consumer Healthcare Business

By GSK | March 27, 2018

ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine)

By GSK | March 20, 2018

GSK Starts Phase III Study of Benlysta and Rituximab Combination in Systemic Lupus Erythematosus

By GSK | March 9, 2018

Positive EU Approval for Labeling Update to GSK’s Relvar Ellipta

By GSK | March 7, 2018

New Data Demonstrate High Efficacy of Fluarix Tetra (Flu Vaccine) in Children

By GSK | February 7, 2018

GSK’s Meningitis B Vaccine Receives Breakthrough Therapy Designation from FDA

By GSK | October 19, 2017

GSK Receives WHO Prequalification for Synflorix Pneumococcal Vaccine Four-Dose Vial

By GSK | September 19, 2017

GSK, Innoviva Gain FDA Approval for First Once-Daily Single Inhaler Triple COPD Therapy

By GSK | July 25, 2017

GSK Submits U.S. Regulatory Filing of Arnuity Ellipta in Children With Asthma

By GSK | June 27, 2017

GSK Presents Positive Results from Phase 3 Shingrix Study